These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9842467)

  • 1. [Identification of metabolic pathways of brain angiotensin II and angiotensin III: predominant role of angiotensin III in the control of vasopressin secretion].
    Llorens-Cortes C
    C R Seances Soc Biol Fil; 1998; 192(4):607-18. PubMed ID: 9842467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.
    Zini S; Fournie-Zaluski MC; Chauvel E; Roques BP; Corvol P; Llorens-Cortes C
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11968-73. PubMed ID: 8876246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III.
    Réaux A; de Mota N; Zini S; Cadel S; Fournié-Zaluski MC; Roques BP; Corvol P; Llorens-Cortès C
    Neuroendocrinology; 1999 May; 69(5):370-6. PubMed ID: 10343178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
    Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
    Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminopeptidase A inhibitors as potential central antihypertensive agents.
    Reaux A; Fournie-Zaluski MC; David C; Zini S; Roques BP; Corvol P; Llorens-Cortes C
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13415-20. PubMed ID: 10557335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of brain angiotensins II and III in thirst and sodium appetite.
    Wilson WL; Roques BP; Llorens-Cortes C; Speth RC; Harding JW; Wright JW
    Brain Res; 2005 Oct; 1060(1-2):108-17. PubMed ID: 16182260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vasopressinergic neurons by central injection of a specific aminopeptidase A inhibitor.
    Zini S; Demassey Y; Fournié-Zaluski MC; Bischoff L; Corvol P; Llorens-Cortès C; Sanderson P
    Neuroreport; 1998 Mar; 9(5):825-8. PubMed ID: 9579673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors.
    Gao J; Marc Y; Iturrioz X; Leroux V; Balavoine F; Llorens-Cortes C
    Clin Sci (Lond); 2014 Aug; 127(3):135-48. PubMed ID: 24697296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin III: a central regulator of vasopressin release and blood pressure.
    Reaux A; Fournie-Zaluski MC; Llorens-Cortes C
    Trends Endocrinol Metab; 2001; 12(4):157-62. PubMed ID: 11295571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II and its fragments (angiotensins III and IV) decrease the growth of DU-145 prostate cancer in vitro.
    Ławnicka H; Potocka AM; Juzala A; Fournie-Zaluski MC; Pawlikowski M
    Med Sci Monit; 2004 Nov; 10(11):BR410-3. PubMed ID: 15507845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminopeptidase A inhibitors as centrally acting antihypertensive agents.
    Bodineau L; Frugière A; Marc Y; Claperon C; Llorens-Cortes C
    Heart Fail Rev; 2008 Sep; 13(3):311-9. PubMed ID: 18175217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of angiotensin II conversion to angiotensin III increases water but not alcohol consumption in aminopeptidase A-deficient mice.
    Faber F; Gembardt F; Sun X; Mizutani S; Siems WE; Walther T
    Regul Pept; 2006 Sep; 136(1-3):130-7. PubMed ID: 16889841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dietary sodium on the blood pressure and renal sympathetic nerve activity responses to intracerebroventricular angiotensin II and angiotensin III in anaesthetized rats.
    Houghton BL; Huang C; Johns EJ
    Exp Physiol; 2010 Feb; 95(2):282-95. PubMed ID: 19880539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.
    Fournie-Zaluski MC; Fassot C; Valentin B; Djordjijevic D; Reaux-Le Goazigo A; Corvol P; Roques BP; Llorens-Cortes C
    Proc Natl Acad Sci U S A; 2004 May; 101(20):7775-80. PubMed ID: 15136730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats.
    Wright JW; Tamura-Myers E; Wilson WL; Roques BP; Llorens-Cortes C; Speth RC; Harding JW
    Am J Physiol Regul Integr Comp Physiol; 2003 Mar; 284(3):R725-33. PubMed ID: 12433674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system.
    Gammelgaard I; Wamberg S; Bie P
    Acta Physiol (Oxf); 2006 Oct; 188(2):129-38. PubMed ID: 16948800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug.
    Balavoine F; Azizi M; Bergerot D; De Mota N; Patouret R; Roques BP; Llorens-Cortes C
    Clin Pharmacokinet; 2014 Apr; 53(4):385-95. PubMed ID: 24337978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the brain renin-angiotensin system in hypertension: implications for new treatment.
    Marc Y; Llorens-Cortes C
    Prog Neurobiol; 2011 Oct; 95(2):89-103. PubMed ID: 21763394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension.
    Hmazzou R; Marc Y; Flahault A; Gerbier R; De Mota N; Llorens-Cortes C
    Clin Sci (Lond); 2021 Mar; 135(6):775-791. PubMed ID: 33683322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats.
    Padia SH; Kemp BA; Howell NL; Fournie-Zaluski MC; Roques BP; Carey RM
    Hypertension; 2008 Feb; 51(2):460-5. PubMed ID: 18158338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.